Aluna, an award-winning linked care platform and at-home spirometer, and ModuleMD, an ONC-certified EHR, announced a partnership on February 6, 2023, to give more patients and providers access to the latest lung health technology.
Asthma and cystic fibrosis patients can now effortlessly share their daily lung health variations with their doctor, improving results and reducing attacks through earlier and more frequent interventions.
This cooperation will enable easy exchange between physicians, payers, and patients on the Aluna RPM care management platform, with all details incorporated into ModuleMD providers' workflow.
Charvi Shetty, Founder and CEO of Aluna, stated, "Close monitoring of asthma and other lung conditions is correlated with better patient outcomes." "Providers seeking to provide the highest quality care with Aluna can do so efficiently and profitably for their practice, now fully integrated with ModuleMD," she added.
(Source – Cision PR Newswire)
Abhinay Rao, CEO of ModuleMD, remarked, "This partnership represents an important shift in the way clinicians provide patient centered care. For true efficiency, everything needs to be connected to the system of record." He added, "At ModuleMD, our mission is to lead innovation in allergy and pulmonology technology. Through this integration with Aluna, medical practices now have a seamless RPM experience to deliver comprehensive care to patients."
(Source – Cision PR Newswire)
About Aluna
Aluna, a digital spirometry platform certified for use by FDA, gives asthma sufferers and their doctors the ability to monitor their lung function in real-time remotely. The Aluna platform allows practices to offer improved medical care to their patients while simultaneously generating an additional revenue stream through reimbursements for remote patient monitoring (RPM).